A clinical research study for Systemic Sclerosis
Summary
A clinical research study to evaluating the safety and effectiveness of an
investigational drug(Anifrolumab) in study participants diagnosed with Systemic Sclerosis
Eligibility
Eligible gender: Male, Female
Eligible ages: 18 to 70
Inclusion criteria:
You may be eligible to participate in this trial if you are:
- 18 to 70 years of age
- have been diagnosed with Systemic Sclerosis
Doctors will also evaluate other criteria to make sure you qualify for the study.
Exclusion criteria:
You may not be eligible to participate in this trial if you:
- have received transplantation
- have a history of malignancy
- female who is breastfeeding or pregnant
Doctors will also evaluate other criteria to make sure you qualify for the study.
Participate
Fill out the following form if you want to participate in this research
Collection of personal information
Your personal information is collected under
the authority of section 33(c) of the Freedom of Information and Protection of Privacy Act. If
you have any questions about the collection or use of this information, please visit our
Access to Information page.
Additional information
Contact information
Please reach out to the study team at 5878304911 or may.choi@ucalgary.ca
Principal investigator:
May Choi
Clinical trial:
Yes
REB-ID:
REB23-0918